申请人:The University of Queensland
公开号:US10933049B2
公开(公告)日:2021-03-02
The present invention discloses the use of a complement 3a receptor (C3aR) antagonist and a mobilizer of hematopoietic stem cells and/or progenitor cells in methods and compositions for stimulating or enhancing the development, mobilization, proliferation and/or differentiation of a neutrophil-containing leukocyte population that inhibits growth and/or spread of a tumor and for treating or preventing a hyperproliferative cell disorder.
本发明公开了补体3a受体(C3aR)拮抗剂和造血干细胞和/或祖细胞动员剂在刺激或增强含中性粒细胞的白细胞群的发育、动员、增殖和/或分化的方法和组合物中的应用,该方法和组合物能抑制肿瘤的生长和/或扩散,并能治疗或预防细胞过度增殖症。